• Subscriptions
  • Contact
Documenta Haematologica - Revista Romana de Hematologie
  • About Us
  • Editorial Board
  • Current Issue
  • Archive
    • 2023 Volume 1
      • Issue 1
      • Issue 2
      • Issue 3
      • Issue 4
    • 2024 Volume 2
      • Issue 1
      • Issue 2
      • Issue 3
      • Issue 4
    • 2025 Volume 3
      • 2025, Volume 3, Issue 1
      • 2025, Volume 3, Issue 2
      • 2025, Volume 3, Issue 3
      • 2025, Volume 3, Issue 4
    • 2026 Volume 4
      • 2026, Volume 4, Issue 1
      • 2026, Volume 4, Issue 2
  • Editorial Process & Peer Review
  • Ethics and Rights
  • How To Submit
Select Page

Cutaneous Complications after Autologous Stem Cell Transplantation

by Catalin | Jul 29, 2024 | 2024 vol. 2 Issue 2

Cutaneous Complications after Autologous Stem Cell Transplantation Ana-Maria ILINESCU, Ana-Maria VLADAREANU, Elena Georgiana ENE, Iuliana IORDAN, Horia BUMBEA Autologous stem cell transplantation (ASCT) has become more prevalent for high-grade non-Hodgkin’s...

Real-World Treatment Patterns and Clinical Outcomes in Unfit AML Patients: Results of Current Retrospective Study in Romania

by Catalin | Jul 29, 2024 | 2024 vol. 2 Issue 2

Real-World Treatment Patterns and Clinical Outcomes in Unfit AML Patients: Results of Current Retrospective Study in Romania Sabina ILUTA, Angela Smaranda DASCALESCU, Alexandra Elena GHIAUR, Ciprian TOMULEASA, Geanina STINGU Aim: The incidence of acute myeloid...

Quantitative BCR::ABL1 Assay Using Digital Real-Time PCR System: Clinical Applications and Insights

by Catalin | Jul 29, 2024 | 2024 vol. 2 Issue 2

Quantitative BCR::ABL1 Assay Using Digital Real-Time PCR System: Clinical Applications and Insights Madalina CIRNU, Dan-Cristian MARINESCU, Cosmin-Florentin NICULAE, Stefania-Andreea NEGRU, Andreea-Alexandra URECHE-FOTEA, Dan-Sebastian SOARE, Horia BUMBEA, Eugen RADU...

Enhancing Multiple Myeloma Treatment Outcomes with Ixazomib: Insights and Perspectives

by Catalin | Jul 29, 2024 | 2024 vol. 2 Issue 2

Enhancing Multiple Myeloma Treatment Outcomes with Ixazomib: Insights and Perspectives Bianca CONSTANTIN, Sanziana BARBU, Larisa ZIDARU, Loredana CIRLAN, Mihnea GAMAN, Sorina BADELITA Introduction: Multiple myeloma (MM) is a hematologic malignancy characterized by the...

The Experience of Timisoara Hematology Clinic on the Management of Aggressive Non-Hodgkin Lymphoma Patients

by Catalin | Jul 29, 2024 | 2024 vol. 2 Issue 2

The Experience of Timisoara Hematology Clinic on the Management of Aggressive Non-Hodgkin Lymphoma Patients Sandra LAZAR, Despina Calamar POPOVICI, Oana SARAU, Luisa ALBA, Dacian Nicolae OROS, Ioana IONITA Objectives. One of the most prevalent types of malignant...
« Older Entries
Next Entries »

Recent Posts

  • Nitric Oxide, Tumor Necrosis Factor-α, and Lipid Peroxidation as Biomarkers of Endothelial Injury in Sickle Cell Disease
  • When the Eyes Speak: A Multisystem Challenge with CNS and Orbital Spread Light Chain Myeloma
  • Unmasking VEXAS Syndrome: A Diagnostic Dilemma
  • TP53-Mutated Myelodysplastic Syndrome with Bone Marrow Fibrosis in a Young Adult: A Rare Diagnostic and Therapeutic Challenge
  • Kimura Disease – Not Every Lymphadenopathy is Malignant

Recent Comments

  1. A WordPress Commenter on Hello world!

Copyright © 2025 | Edited by Romanian Society of Hematology